Cargando…

Immunopathogenesis of Pneumonia in COVID-19

Detalles Bibliográficos
Autores principales:	Alipoor, Shamila D., Jamaati, Hamidreza, Tabarsi, Payam, Mortaz, Esmaeil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Research Institute of Tuberculosis and Lung Disease 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680509/ https://www.ncbi.nlm.nih.gov/pubmed/33262791

Ejemplares similares

COVID-19: Molecular and Cellular Response
por: Alipoor, Shamila D., et al.
Publicado: (2021)

The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients
por: Alipoor, Shamila D., et al.
Publicado: (2021)

Is There an Ending in Insight for COVID-19?
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)?
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Efficacy of Early Prone Positioning Combined with Noninvasive Ventilation in COVID-19
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2021)

Exosomes in Severe Asthma: Update in Their Roles and Potential in Therapy
por: Mortaz, Esmaeil, et al.
Publicado: (2018)

Bovis Bacillus Calmette–Guerin (BCG) infection induces exosomal miRNA release by human macrophages
por: Alipoor, Shamila D., et al.
Publicado: (2017)

Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis
por: Alipoor, Shamila D., et al.
Publicado: (2019)

The First Symposium on COPD and Therapeutic Approaches 2016, Tehran, Iran
por: Mortaz, Esmaeil, et al.
Publicado: (2017)

Silent hypoxia: higher NO in red blood cells of COVID-19 patients
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Correction to: Silent hypoxia: higher NO in red blood cells of COVID-19 patients
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Nutritional Impact and Its Potential Consequences on COVID-19 Severity
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Comparison of antibacterial activities of cadmium oxide nanoparticles against Pseudomonas Aeruginosa and Staphylococcus Aureus bacteria
por: Salehi, Bahareh, et al.
Publicado: (2015)

Update on Neutrophil Function in Severe Inflammation
por: Mortaz, Esmaeil, et al.
Publicado: (2018)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

NRITLD Protocol for the Management of Outpatient Cases of COVID-19
por: Rezaei, Mitra, et al.
Publicado: (2021)

Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients
por: Mortaz, Esmaeil, et al.
Publicado: (2021)

Exosomes and Exosomal miRNA in Respiratory Diseases
por: Alipoor, Shamila D., et al.
Publicado: (2016)

Immunologic Role of Extracellular Vesicles and Exosomes in the Pathogenesis of Cystic Fibrosis
por: Asef, Alireza, et al.
Publicado: (2018)

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2021)

The roles of miRNAs as potential biomarkers in lung diseases
por: Alipoor, Shamila D., et al.
Publicado: (2016)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
por: Alipoor, Shamila D., et al.
Publicado: (2018)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Continuous versus intermittent administration of piperacillin–tazobactam in intensive care unit patients with ventilator-associated pneumonia
por: Fahimi, Fanak, et al.
Publicado: (2012)

Correction to: Water-pipe smoke condensate increases the internalization of Mycobacterium Bovis of type II alveolar epithelial cells (A549)
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Water-pipe smoke condensate increases the internalization of Mycobacterium Bovis of type II alveolar epithelial cells (A549)
por: Mortaz, Esmaeil, et al.
Publicado: (2017)

Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients
por: Dezfuli, Neda K., et al.
Publicado: (2021)

Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors
por: Atashbasteh, Mostafa, et al.
Publicado: (2021)

No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial
por: Jamaati, Hamidreza, et al.
Publicado: (2021)

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Elevated CXCL-8 expression in bronchoalveolar lavage correlates with disease severity in patients with acute respiratory distress syndrome resulting from tuberculosis
por: Hashemian, Seyed Mohamad Reza, et al.
Publicado: (2014)

The miR-196a SNP Rs11614913 but not the miR-499 rs37464444 SNP is a Risk Factor for Non-small Cell Lung Cancer in an Iranian Population
por: Dezfuli, Neda K., et al.
Publicado: (2022)

Intention to Quit Smoking and Associated Factors in Smokers Newly Diagnosed with Pulmonary Tuberculosis
por: Aryanpur, Mahshid, et al.
Publicado: (2016)

Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients
por: Kiaee, Fatemeh, et al.
Publicado: (2022)

Late Post-Coronavirus Disease 2019 Inflammatory Syndrome: A Case Experience with Tocilizumab
por: Tabarsi, Payam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vesu5gs0296alosees13mmb3ib